Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli

scientific article

Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3389/FMICB.2017.01370
P8608Fatcat IDrelease_les26rwrdfhjrik36xftk6bud4
P932PMC publication ID5516121
P698PubMed publication ID28769919

P50authorJesús MachucaQ41430696
José Manuel Rodríguez MartínezQ54449621
Alvaro PascualQ60594097
Jesus BlazquezQ68273789
P2093author name stringEsther Recacha
Alejandra Briales
Paula Díaz-de-Alba
P2860cites workSublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesisQ24625342
Plasmid-mediated quinolone resistance: a multifaceted threatQ24645356
Genomic transcriptional response to loss of chromosomal supercoiling in Escherichia coliQ24809586
Moving forward with reactive oxygen species involvement in antimicrobial lethalityQ26995546
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR productsQ27860842
The COG database: a tool for genome-scale analysis of protein functions and evolutionQ27936664
A common mechanism of cellular death induced by bactericidal antibioticsQ28246128
Antibiotics induce redox-related physiological alterations as part of their lethality.Q33665248
Multidrug evolutionary strategies to reverse antibiotic resistanceQ33871101
Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates.Q33883590
Two programmed cell death systems in Escherichia coli: an apoptotic-like death is inhibited by the mazEF-mediated death pathwayQ34192779
Reactive oxygen species and the bacterial response to lethal stressQ34624207
Plasmid-mediated quinolone resistanceQ34888920
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coliQ35587954
Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS systemQ35598487
Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coliQ35742369
Antibiotic efficacy is linked to bacterial cellular respiration.Q35845962
Mechanisms of drug resistance: quinolone resistanceQ36225422
Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coliQ36295431
YihE kinase is a central regulator of programmed cell death in bacteriaQ36674733
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance.Q36995736
Induction of plasmid-carried qnrS1 in Escherichia coli by naturally occurring quinolones and quorum-sensing signal molecules.Q37036595
Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.Q37074679
A dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during β-lactam stressQ37105664
Quinolones: action and resistance updatedQ37595559
Plasmid-mediated quinolone resistance: an update.Q37795644
Regulation of growth and death in Escherichia coli by toxin-antitoxin systems.Q37934486
SOS, the formidable strategy of bacteria against aggressions.Q38219786
Molecular mechanisms of antibiotic resistance.Q38272908
Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniaeQ38455501
Effects of Stress, Reactive Oxygen Species, and the SOS Response on De Novo Acquisition of Antibiotic Resistance in Escherichia coliQ38741753
Escherichia coli: an old friend with new tidingsQ38757148
Plasmid-mediated quinolone resistance: Two decades on.Q39027430
Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance MechanismsQ40786561
Contribution of oxidative damage to antimicrobial lethality.Q41808795
Apoptosis-like death, an extreme SOS response in Escherichia coliQ41879514
Perturbation of iron homeostasis promotes the evolution of antibiotic resistance.Q42022178
Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistanceQ42089215
Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.Q42201141
Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolatesQ42234726
In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC.Q42706278
Antioxidative mechanisms protect resistant strains of Staphylococcus aureus against ciprofloxacin oxidative damageQ43088971
Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS productionQ43226870
Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.Q44219139
Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents.Q44433686
Nonmutational compensation of the fitness cost of antibiotic resistance in mycobacteria by overexpression of tlyA rRNA methylaseQ46349510
Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.Q54121629
P921main subjectEscherichia coliQ25419
quinolonesQ426549
P304page(s)1370
P577publication date2017-07-19
P1433published inFrontiers in MicrobiologyQ27723481
P1476titleCellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli
P478volume8

Search more.